OPEN END TURBO CALL-OPTIONSSCHEIN MIT SL - SANOFI Share Price

Certificat

DE000CL7PR29

Real-time Boerse Frankfurt Warrants 09:07:26 23/05/2024 pm IST
1.62 EUR -12.43% Intraday chart for OPEN END TURBO CALL-OPTIONSSCHEIN MIT SL - SANOFI
Current month+16.35%
1 month+58.12%
Date Price Change
23/24/23 1.62 -12.43%
22/24/22 1.85 +16.35%
21/24/21 1.59 +4.61%
20/24/20 1.52 -1.30%
17/24/17 1.54 -2.53%

Real-time Boerse Frankfurt Warrants

Last update May 23, 2024 at 09:07 pm IST

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying SANOFI
IssuerLogo Issuer Société Générale Société Générale
WKN CL7PR2
ISINDE000CL7PR29
Date issued 08/04/2020
Strike 74.11
Maturity Unlimited
Parity 10 : 1
Emission price 1.03
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 3.45
Lowest since issue 0.25
Spread 0.03
Spread %1.82%

Company Profile

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Sector
-
More about the company

Ratings for Sanofi

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Sanofi

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
90.8 EUR
Average target price
108.3 EUR
Spread / Average Target
+19.31%
Consensus